Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade

30 Mar 2007

Abstract excerpt

PURPOSE: A number of microarray studies have reported distinct molecular profiles of breast cancers (BC), such as basal-like, ErbB2-like, and two to three luminal-like subtypes. These were associated with different clinical outcomes. However, although the basal and the ErbB2 subtypes are repeatedly recognized, identification of estrogen receptor (ER) -positive subtypes has been inconsistent. Therefore, refinement...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Breast Lesions and Carcinomas
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17401012
DOI: 10.1200/jco.2006.07.1522

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic GradePMID 17401012Read ↗

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissuesSemantic proximity Read ↗

Understanding the Molecular Basis of Histologic GradeSemantic proximity Read ↗

A Five-Gene Molecular Grade Index and <i>HOXB13:IL17BR</i> Are Complementary Prognostic Factors in Early Stage Breast CancerSemantic proximity Read ↗

A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patientsSemantic proximity Read ↗

Taxonomy of breast cancer based on normal cell phenotype predicts outcome.Semantic proximity Read ↗

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.Semantic proximity Read ↗

Molecular Classification of Estrogen Receptor-positive/Luminal Breast CancersSemantic proximity Read ↗

Grade-specific diagnostic and prognostic biomarkers in breast cancerSemantic proximity Read ↗

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.Semantic proximity Read ↗

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular SubtypesSemantic proximity Read ↗

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platformsSemantic proximity Read ↗

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.